Pura Vida Investments, LLC Amicus Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $396,522 - $488,028	-45,525 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$9.2 - $23.86 $116,609 - $302,425	-12,675 Reduced 21.78%	45,525 $450,000
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $1.35 Million - $2.49 Million	-100,000 Reduced 63.21%	58,200 $1.34 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $720,551 - $888,251	55,900 Added 54.64%	158,200 $2.23 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $906,378 - $1.61 Million	102,300 New	102,300 $1.54 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $381,792 - $612,326	-45,560 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $631,504 - $900,437	-54,440 Reduced 54.44%	45,560 $551,000
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $1.38 Million - $1.71 Million	100,000 New	100,000 $0

313

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.